Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Jyoti, Soni"'
Autor:
Diana Alexandra Echeverria Proano, Fengcai Zhu, Xiaodong Sun, Jesús Zoco, Jyoti Soni, Neeraj Parmar, S. Omar Ali
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
Phase III multi-country studies (ZOE-50/70) demonstrated that the adjuvanted recombinant zoster vaccine (RZV) was well tolerated and prevented herpes zoster (HZ) in healthy ≥ 50-year-olds, with a vaccine efficacy (VE) > 90% across age groups. These
Externí odkaz:
https://doaj.org/article/378899e3d99746fbae93898ecd90c44b
Autor:
Jyoti Soni, Rajesh Pandey
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Host-microbe interactions are complex and ever-changing, especially during infections, which can significantly impact human physiology in both health and disease by influencing metabolic and immune functions. Infections caused by pathogens such as ba
Externí odkaz:
https://doaj.org/article/27e96d14b2cb4680b2e0cd4f9cdd9adb
Publikováno v:
Frontiers in Microbiology, Vol 15 (2024)
Post COVID-19, there has been renewed interest in understanding the pathogens challenging the human health and evaluate our preparedness towards dealing with health challenges in future. In this endeavour, it is not only the bacteria and the viruses,
Externí odkaz:
https://doaj.org/article/5aec3c7e0d674307a764aae184f20aa9
Publikováno v:
Frontiers in Microbiology, Vol 15 (2024)
Bacteria are the most prevalent form of microorganisms and are classified into two categories based on their mode of existence: intracellular and extracellular. While most bacteria are beneficial to human health, others are pathogenic and can cause m
Externí odkaz:
https://doaj.org/article/35e3203b91df41e3b5da13b172a8c795
Autor:
Jyoti Soni, Partha Chattopadhyay, Priyanka Mehta, Ramakant Mohite, Kishore Tardalkar, Meghnad Joshi, Rajesh Pandey
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
IntroductionSingle-cell multi-omics studies, such as multidimensional transcriptomics (whole transcriptomic analysis, WTA), and surface marker analysis (antibody sequencing, AbSeq), have turned out to be valuable techniques that offer inaccessible po
Externí odkaz:
https://doaj.org/article/7c3be4b86daa453fb12c000adc65fcb2
Autor:
Partha Chattopadhyay, Pallavi Mishra, Priyanka Mehta, Jyoti Soni, Rohit Gupta, Bansidhar Tarai, Sandeep Budhiraja, Rajesh Pandey
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
IntroductionThe emergence of multiple variants of concerns (VOCs) with higher number of Spike mutations have led to enhanced immune escape by the SARS-CoV-2. With the increasing number of vaccination breakthrough (VBT) infections, it is important to
Externí odkaz:
https://doaj.org/article/b6fb7e4e671143308c7aeb57bf459a89
Autor:
Cristiano A.F. Zerbini, Rodrigo Ribeiro dos Santos, Maria Jose Nunes, Jyoti Soni, Ping Li, Varsha K. Jain, Opokua Ofori-Anyinam
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 21, Iss 1, Pp 63-70 (2017)
The World Health Organization influenza forecast now includes an influenza B strain from each of the influenza B lineages (B/Yamagata and B/Victoria) for inclusion in seasonal influenza vaccines. Traditional trivalent influenza vaccines include an in
Externí odkaz:
https://doaj.org/article/2897dd13af77414595a44b37a39783d9
Autor:
Ji-Young Min, Agnes Mwakingwe-Omari, Megan Riley, Lifeter Yenwo Molo, Jyoti Soni, Ginette Girard, Jasur Danier
Publikováno v:
The Journal of infection. 84(4)
Herpes zoster (HZ) results from reactivation of latent varicella-zoster virus. Adults at increased risk of HZ (due to immunocompromising conditions or older age) are also at risk of pneumococcal disease, both of which are preventable by vaccination.
Autor:
Jasur Danier, Pope Kosalaraska, Alfoso Carmona, Andrea Callegaro, Luis Rivera, Khalequ Zaman, Jerome Wilson, Jyoti Soni, Damien Friel, Ghassan Dbaibo, Anne Schuind, Wenji Pu, Valerie Vantomme, Bruce L. Innis
Publikováno v:
Open Forum Infectious Diseases
Background Data from a randomized controlled efficacy trial of an inactivated quadrivalent influenza vaccine in children 6–35 months of age were used to determine whether hemagglutination inhibition (HI) antibody titer against A/H1N1 and A/H3N2 is
Autor:
Jasur, Danier, Luis, Rivera, Carine, Claeys, Ghassan, Dbaibo, Varsha K, Jain, Pope, Kosalaraksa, Wayne, Woo, Emad, Yanni, Khalequ, Zaman, Beatriz, Acosta, Arshad, Amanullah, Miguel, Ariza, Maria, Luisa Arroba Basanta, Ashish, Bavdekar, Alfonso, Carmona, Luis, Cousin, Adolfo, Diaz, Javier, Diez-Domingo, Ener, Cagri Dinleyici, Saul N, Faust, Jose, Garcia-Sicilia, Grace D, Gomez-Go, Liza, Antionette Gonzales, Mustafa, Hacimustafaoglu, Stephen M, Hughes, Allen, Izu, Teresa, Jackowska, Shashi, Kant, Marilla, Lucero, Josep, Mares Bermudez, Federico, Martinón-Torres, May, Montellano, Roman, Prymula, Thanyawee, Puthanakit, Renata, Ruzkova, Iwona, Sadowska-Krawczenko, Jyoti, Soni, Henryk, Szymanski, Angels, Ulied, Anne, Schuind, Bruce L, Innis, K, Zaman
Publikováno v:
PEDIATRIC INFECTIOUS DISEASE JOURNAL
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Background: In an exploratory analysis of an inactivated quadrivalent influenza vaccine (IIV4) trial in children 6-35 months without risk factors for influenza, we evaluated clinical presentation of influenza illness and vaccine impact on health outc